Compare · CPAA vs EUCR
CPAA vs EUCR
Side-by-side comparison of Conyers Park III Acquisition Corp. (CPAA) and Eucrates Biomedical Acquisition Corp. (EUCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CPAA and EUCR operate in Blank Checks (Finance), so they compete in similar markets.
EUCR
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest CPAA
- SEC Form SC 13G/A filed by Conyers Park III Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Conyers Park III Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by Conyers Park III Acquisition Corp.
- SEC Form 25-NSE filed by Conyers Park III Acquisition Corp.
- Conyers Park III Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by Conyers Park III Acquisition Corp.
- Conyers Park III Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by Conyers Park III Acquisition Corp.
- SEC Form 10-K filed by Conyers Park III Acquisition Corp.
- SEC Form SC 13G/A filed by Conyers Park III Acquisition Corp. (Amendment)
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)